Flow cytometric analyses of TILs revealed that L-NAME combined with an anti-PD-1 blockade tended to decrease tumor-infiltrating CD4+FOXP3+ regulatory T cells, and significantly increased the CD8+/CD4+FOXP3+ ratio in MCA205WT tumors (Fig. 6c). Here, CD8A is linked to neoplasm.